Mild Neurocognitive disorder: An old wine in a new bottle

Harvard Review of Psychiatry

Volumn 23, Issue 5, 2015, Pages 368-376

  Stokin, Gorazd B ^a   Krell Roesch, Janina ^a,b   Petersen, Ronald C ^c   Geda, Yonas E ^a,b  

^a International Clinical Research Center   (Czech Republic)

^b MAYO CLINIC   (United States)

^c MAYO CLINIC   (United States)

Author keywords

cognitive disorders; dementia; DSM 5; mild cognitive impairment; mild neurocognitive disorder

Indexed keywords

BIOLOGICAL MARKER;

AGING; CLINICAL FEATURE; DEMENTIA; DSM-5; DSM-IV; EDUCATIONAL STATUS; GROUPS BY AGE; HUMAN; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; AGED; CLASSIFICATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; FEMALE; GERIATRIC ASSESSMENT; MALE; MENTAL HEALTH; NEUROPSYCHOLOGICAL TEST; PROCEDURES; PSYCHOLOGICAL RATING SCALE; STANDARDS; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MALE; MENTAL HEALTH; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES;

EID: 84942054027     PISSN: 10673229     EISSN: 14657309     Source Type: Journal    
DOI: 10.1097/HRP.0000000000000084     Document Type: Review

References (62)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: APA, 2013.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: APA, 1994.
3. Sachdev PS, Blacker D, Blazer DG, Classifying neurocognitive disorders: the DSM-5 approach. Nat Rev Neurol 2014; 10: 634-42.
4. Ganguli M, Blacker D, Blazer DG, Classification of neurocognitive disorders in DSM-5: a work in progress. Am J Geriatr Psychiatry 2011; 19: 205-10.
5. Ganguli M,. Can the DSM-5 framework enhance the diagnosis of MCI? Neurology 2013; 81: 2045-50.
6. Winblad B, Palmer K, Kivipelto M, Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004; 256: 240-6.
7. Petersen RC,. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256: 183-94.
8. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E,. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303-8.
9. Petersen RC, Roberts RO, Knopman DS, Mild cognitive impairment: ten years later. Arch Neurol 2009; 66: 1447-55.
10. Albert MS, DeKosky ST, Dickson D, The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dement 2011; 7: 270-9.
11. Petersen RC, Caracciolo B, Brayne C, Gauthier S, Jelic V, Fratiglioni L,. Mild cognitive impairment: a concept in evolution. J Intern Med 2014; 275: 214-28.
12. Blazer D,. Neurocognitive disorders in DSM-5. Am J Psychiatry 2013; 170: 585-7.
13. Reisberg B, Ferris SH, de Leon MJ, Stage-specific behavioral, cognitive, and in vivo changes in community residing subjects with age-associated memory impairment and primary degenerative dementia of the Alzheimer type. Drug Dev Res 1988; 15: 101-14.
14. Levy R,. Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr 1994; 6: 63-8.
15. Kral VA,. Senescent forgetfulness: benign and malignant. Can Med Assoc J 1962; 86: 257-60.
16. Hughes CP, Berg L, Danzinger WL, Coben LA, Martin RL,. A new clinical scale for the staging of dementia. Brit J Psychiatry 1982; 140: 566-72.
17. Devanand DP, Folz M, Gorlyn M, Moeller JR, Stern Y,. Questionable dementia: clinical course and predictors of outcome. J Am Geriatr Soc 1997; 45: 321-8.
18. Crook T, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Gershon S,. Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change-report of a National Institute of Mental Health work group. Dev Neuropsych 1986; 2: 261-76.
19. Blackford RC, La Rue A,. Criteria for diagnosing age-associated memory impairment: proposed improvements from the field. Dev Neuropsychol 1989; 5: 295-306.
20. Graham JE, Rockwood K, Beattie BL, Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997; 349: 1793-6.
21. Smith GE, Rush BK,. Normal aging and mild cognitive impairment. In: Attix DK, Welsh-Bohmer KA, eds. Geriatric neuropsychology: assessment and intervention. New York: Guilford, 2006.
22. Geda YE, Nedelska Z,. Mild cognitive impairment: a subset of minor neurocognitive disorder. ? Am J Geriatr Psychiatry 2012; 20: 821-6.
23. Petersen RC, Thomas RG, Grundman M, Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005; 352: 2379-88.
24. Morris JC, Cummings J,. Mild cognitive impairment (MCI) represents early-stage Alzheimer's disease. J Alzheimers Dis 2005; 7: 235-9; discussion 55-62.
25. Morris JC,. Mild cognitive impairment is early-stage Alzheimer disease: time to revise diagnostic criteria. Arch Neurol 2006; 63: 15-6.
26. Morris JC, Storandt M, Miller JP, Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001; 58: 397-405.
27. Dubois B, Albert ML,. Amnestic MCI or prodromal Alzheimer's disease? Lancet Neurol 2004; 3: 246-8.
28. Dubois B, Feldman HH, Jacova C, Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6: 734-46.
29. Sperling RA, Aisen PS, Beckett LA, Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 280-92.
30. Folstein MF, Folstein SE, McHugh PR,. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
31. Nasreddine ZS, Phillips NA, Bedirian V, The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695-9.
32. Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR,. The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 2006; 21: 1078-85.
33. Kokmen E, Naessens JM, Offord KP,. A short test of mental status: description and preliminary results. Mayo Clin Proc 1987; 62: 281-8.
34. Caselli RJ, Dueck AC, Osborne D, Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N Engl J Med 2009; 361: 255-63.
35. Verghese J, Lipton RB, Katz MJ, Leisure activities and the risk of dementia in the elderly. N Engl J Med 2003; 348: 2508-16.
36. Verghese J, LeValley A, Derby C, Leisure activities and the risk of amnestic mild cognitive impairment in the elderly. Neurology 2006; 66: 821-7.
37. Geda YE, Roberts RO, Knopman DS, Physical exercise, aging, and mild cognitive impairment: a population-based study. Arch Neurol 2010; 67: 80-6.
38. Rey A,. L'examen clinique en psychologie. Paris: Presses universitaires de France, 1964.
39. Wechsler D,. Wechsler Memory Scale-Revised. New York: Psychological Corporation, 1987.
40. Kaplan E, Goodglass H, Brand S,. Boston Naming Test. Philadelphia: Lea & Febiger, 1983.
41. Lucas JA, Ivnik RJ, Smith GE, Mayo's older Americans normative studies: category fluency norms. J Clin Exp Neuropsychol 1998; 20: 194-200.
42. Reitan RM,. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 1958; 8: 271-6.
43. Wechsler D,. Wechsler Adult Intelligence Scale-Revised. New York: Psychological Corporation, 1981.
44. Jack CR Jr, Knopman DS, Jagust WJ, Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010; 9: 119-28.
45. Klunk WE, Engler H, Nordberg A, Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004; 55: 306-19.
46. Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L,. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 2006; 5: 228-34.
47. Dickerson BC, Salat DH, Bates JF, Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol 2004; 56: 27-35.
48. Dickerson BC, Stoub TR, Shah RC, Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurology 2011; 76: 1395-402.
49. Jack CR Jr, Petersen RC, Xu Y, Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 2000; 55: 484-9.
50. Jack CR Jr, Petersen RC, Xu YC, Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999; 52: 1397-403.
51. Ganguli M, Dodge HH, Shen C, DeKosky ST,. Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology 2004; 63: 115-21.
52. Hanninen T, Hallikainen M, Tuomainen S, Vanhanen M, Soininen H,. Prevalence of mild cognitive impairment: a population-based study in elderly subjects. Acta Neurol Scand 2002; 106: 148-54.
53. Petersen RC, Roberts RO, Knopman DS, Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging. Neurology 2010; 75: 889-97.
54. Larrieu S, Letenneur L, Orgogozo JM, Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology 2002; 59: 1594-9.
55. Sachs-Ericsson N, Blazer DG,. The new DSM-5 diagnosis of mild neurocognitive disorder and its relation to research in mild cognitive impairment. Aging Ment Health 2015; 19: 2-12.
56. Rabins PV, Lyketsos CG,. A commentary on the proposed DSM revision regarding the classification of cognitive disorders. Am J Geriatr Psychiatry 2011; 19: 201-4.
57. Looi JC, Velakoulis D,. Major and minor neurocognitive disorders in DSM-5: the difference between the map and the terrain. Aust N Z J Psychiatry 2014; 48: 284-6.
58. Mitchell AJ,. Redefining the syndrome of cognitive impairment in DSM-5. Aust N Z J Psychiatry 2013; 47: 779-80.
59. Snelgrove TA, Hasnain M,. A concern about the proposed DSM-V criteria reclassifying cognitive disorders. Am J Geriatr Psychiatry 2012; 20: 543.
60. Rascovsky K, Hodges JR, Knopman D, Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011; 134: 2456-77.
61. Lopez-Anton R, Santabarbara J, De-la-Camara C, Mild cognitive impairment diagnosed with the new DSM-5 criteria: prevalence and associations with non-cognitive psychopathology. Acta Psychiatr Scand 2015; 131: 29-39.
62. Breitner JC,. Observations on DSM-5 mild neurocognitive disorder vs. its predecessor, mild cognitive impairment. Acta Psychiatr Scand 2015; 131: 15-7.